L. Varga

879 total citations
23 papers, 678 citations indexed

About

L. Varga is a scholar working on Surgery, Ecology, Evolution, Behavior and Systematics and Molecular Biology. According to data from OpenAlex, L. Varga has authored 23 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Ecology, Evolution, Behavior and Systematics and 3 papers in Molecular Biology. Recurrent topics in L. Varga's work include Plant and fungal interactions (4 papers), Gastrointestinal motility and disorders (2 papers) and Ovarian function and disorders (2 papers). L. Varga is often cited by papers focused on Plant and fungal interactions (4 papers), Gastrointestinal motility and disorders (2 papers) and Ovarian function and disorders (2 papers). L. Varga collaborates with scholars based in Switzerland, Canada and Germany. L. Varga's co-authors include R. Wenner, E. del Pozo, Henry G. Friesen, J S Pryor, R. Brun del Re, G. Tolis, H.J. Wyss, F Halter, Beatrice Flogerzi and U Scheurer and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Gut and American Journal of Obstetrics and Gynecology.

In The Last Decade

L. Varga

22 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Varga Switzerland	11	308	128	85	81	79	23	678
S. S. LYNCH United Kingdom	20	277 0.9×	305 2.4×	77 0.9×	39 0.5×	137 1.7×	43	761
Porsha Smith United States	12	187 0.6×	50 0.4×	84 1.0×	58 0.7×	220 2.8×	19	664
Thomas W. Hurley United States	14	250 0.8×	115 0.9×	49 0.6×	140 1.7×	187 2.4×	28	791
Vicente Díaz‐Sánchez Mexico	17	255 0.8×	234 1.8×	109 1.3×	38 0.5×	157 2.0×	36	775
Carlos A.E. Lemmi United States	10	70 0.2×	50 0.4×	64 0.8×	35 0.4×	118 1.5×	32	333
Elinor M. Zorn United States	13	257 0.8×	150 1.2×	87 1.0×	139 1.7×	104 1.3×	24	600
H.‐D. Taubert Germany	16	217 0.7×	322 2.5×	26 0.3×	51 0.6×	91 1.2×	66	668
EUGENIA ROSEMBERG United States	17	366 1.2×	360 2.8×	119 1.4×	72 0.9×	270 3.4×	59	900
M C Raux-Demay France	16	548 1.8×	113 0.9×	96 1.1×	43 0.5×	433 5.5×	26	806
Keith L. Blauer United States	9	137 0.4×	108 0.8×	68 0.8×	53 0.7×	34 0.4×	20	424

Countries citing papers authored by L. Varga

Since Specialization

Citations

This map shows the geographic impact of L. Varga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Varga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Varga more than expected).

Fields of papers citing papers by L. Varga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Varga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Varga. The network helps show where L. Varga may publish in the future.

Co-authorship network of co-authors of L. Varga

This figure shows the co-authorship network connecting the top 25 collaborators of L. Varga. A scholar is included among the top collaborators of L. Varga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Varga. L. Varga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lichardus, B, et al.. (2015). Renal Salt-Wasting Increases Vasopressin Excretion in Preterm Infants. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. 12. 179–184. 2 indexed citations

Arni, Stephan, L. Varga, Bruno M. Balsiger, et al.. (2006). Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 18(8). 889–894. 13 indexed citations

Konrad, Astrid, Michael Mähler, Beatrice Flogerzi, et al.. (2003). Amelioration of Murine Colitis by Feeding a Solution of LysedEscherichia coli. Scandinavian Journal of Gastroenterology. 38(2). 172–179. 26 indexed citations

Schmassmann, Adrian, Andrzej S. Tarnawski, Beatrice Flogerzi, et al.. (1994). Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole.. Gut. 35(7). 896–904. 22 indexed citations

Döbrönte, Z, et al.. (1992). [Treatment of carcinoid syndrome with a somatostatin analogue].. PubMed. 133(12). 731–4. 1 indexed citations

Sj, Konturek, et al.. (1986). Effects of secretin antibody on gastric acid inhibition and pancreatic bicarbonate stimulation by acidified liver extract meal in dogs.. PubMed. 33(4). 170–5. 2 indexed citations

Koelz, H. R., Regina Fritsche, Otfried Müller, et al.. (1986). Structure and function of gastric corpus mucosa in suckling rats after treatment with 16,16-dimethyl prostaglandin E2. Prostaglandins. 31(1). 133–141. 5 indexed citations

Scheurer, U, et al.. (1983). Measurement of cholecystokinin octapeptide-induced motility of rat antrum, pylorus, and duodenum in vitro. American Journal of Physiology-Gastrointestinal and Liver Physiology. 244(3). G261–G265. 17 indexed citations

Varga, L., et al.. (1975). Pituitary and ovarian response patterns to stimulation in the postpartum and in galactorrhea-amenorrhea. The role of prolactin.. PubMed. 46(5). 539–43. 31 indexed citations

10.

Varga, L., Imke Metz, & Ezra Steiger. (1974). Another case of ovarian pregnancy in a patient with IUD. Archives of Gynecology and Obstetrics. 217(3). 289–292. 2 indexed citations

11.

Pozo, E. del, L. Varga, H.J. Wyss, et al.. (1974). Clinical and Hormonal Response To Bromocriptin (CB-154) in the Galactorrhea Syndromes. The Journal of Clinical Endocrinology & Metabolism. 39(1). 18–26. 145 indexed citations

12.

Varga, L., et al.. (1974). [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: I. A comparative study with 2-Br-alpha-ergocryptine in different dosages and placebo (author's transl)].. PubMed. 34(10). 882–4. 1 indexed citations

13.

Varga, L., R. Wenner, & E. del Pozo. (1974). TREATMENT OF GALACTORRHEA-AMENORRHEA SYNDROME WITH BR-ERGOCRYPTINE (CB 154). Obstetrical & Gynecological Survey. 29(6). 422–423.

14.

Varga, L. & R. Wenner. (1973). [Progressive growth of a primary tumour due to pregnancy].. PubMed. 33(4). 288–93. 1 indexed citations

15.

Varga, L., R. Wenner, & E. del Pozo. (1973). Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): Restoration of ovulatory function and fertility. American Journal of Obstetrics and Gynecology. 117(1). 75–79. 37 indexed citations

16.

Varga, L., et al.. (1972). Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study. BMJ. 2(5816). 743–744. 98 indexed citations

17.

Wenner, R. & L. Varga. (1972). PROLACTINHEMMUNG MITTELS ERGOCRYPTIN. European Journal of Endocrinology. 68(3_Suppl). S40–S40. 2 indexed citations

18.

Pozo, E. del, R. Brun del Re, L. Varga, & Henry G. Friesen. (1972). THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine). The Journal of Clinical Endocrinology & Metabolism. 35(5). 768–771. 156 indexed citations

19.

Pryor, J S, et al.. (1971). Treatment of Non-puerperal Galactorrhoea with an Ergot Alkaloid. BMJ. 3(5768). 228–229. 91 indexed citations

20.

Bartók, I, L. Varga, & Gábor Varga. (1970). [Electron microscopic changes in the rat liver after administration of the oral contraceptive lynestrenol].. PubMed. 17(1). 1–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact